The anti-tumour and pro-tumour roles of Th1/Th2 immune cells and M1/M2 macrophages have been documented by numerous experimental studies. However, it is still unknown how these immune cells interact with each other to control tumour dynamics. Here, we use a mathematical model for the interactions between mouse melanoma cells, Th2/Th1 cells and M2/M1 macrophages, to investigate the unknown role of the re-polarisation between M1 and M2 macrophages on tumour growth. The results show that tumour growth is associated with a type-II immune response described by large numbers of Th2 and M2 cells. Moreover, we show that: (i) the ratio k of the transition rates k 12 (for the re-polarisation M1→M2) and k 21 (for the repolarisation M2→M1) is important in reducing tumour population, and (ii) the particular values of these transition rates control the delay in tumour growth and the final tumour size. We also perform a sensitivity analysis to investigate the effect of various model parameters on changes in the tumour cell population, and confirm that the ratio k alone and the ratio of M2 and M1 macrophage populations at earlier times (e.g., day 7), cannot always predict the final tumour size.
Introduction
investigate the steady states of this model, and their stability. In Section 4
we study the dynamics of the model using numerical simulations. In Section 113 5 we perform a sensitivity analysis for the parameters and initial conditions 114 of the model. We conclude in Section 6 with a summary and discussion of 115 the results. dx T n dt =rx T n 1 − x T n + x T s β T + k sn x T s − δ mn x M 1 x T n + r mn x T n x M 2 , (1a)
interactions with other cells); see, for example, Louzoun et al. (2014) . Never-theless, the goal of our study is not to investigate all these possible modelling 185 approaches; rather is to choose one way of describing the interactions, and 186 use it to investigate the anti-tumour type-I and type-II immune responses. To investigate the dynamics of system (1), we first focus on its long-term 189 behaviour as described by the number and stability of the steady states.
190
By calculating these states, we aim to emphasise the complex dynamics of 191 equations (1), and the difficulty of fully understanding this dynamics. 3.1. Tumour-free steady states
193
We first study the case when x T n = x T s = 0. For the baseline para-
194
meter values used here and listed in Table A .2, these tumour-free states are 195 generally unstable (see the discussion in AppendixC). We therefore expect 196 the dynamics of system (1) to move away from these states -as it will be with x * T n = β T r (r − δ mn x * M 1 ), (5a)
For the baseline parameter values used in this article, the TP1IP state 224 is unique (see AppendixB). Moreover this state is unstable and the 225 dynamics of system (1) will not evolve towards it (see AppendixC).
226
• Tumour-Present Type-II Immune Response Present (TP2IP) states: ) , x * T h2 = δ m2 − a n x * T n (1 −
Also this state is unique and stable for the parameter values used in 228 this article -as confirmed by the numerical simulations in Figure 3 .
229
• Tumour-Present Immune-Present (TPIP) states:
with x * T s = 0 or x * T s > 0. As we will see throughout the next sec- that the stability of these states depends also on the ratio k = k 12 /k 21 . 
Numerical results

238
Next, we study the dynamics of model (1) through numerical simula- Tables A.1 and   256 A.2). We first notice that the x T n cells grow to the carrying capacity while 257 the x T s cells are eliminated (Fig. 3A) . Moreover, as seen in the experimental 258 results (Fig. 2B) , there is a shift in the macrophage profile: from a x M 1 259 profile for t < 10 days to a x M 2 profile for t > 10 days (Fig. 3B ). This shift 260 is accompanied by a shift in the Th profile: from a Th1-dominated dynamics 261 during the first ≈ 15 days (Fig. 3C ) to a Th2-dominated dynamics at a later 262 time (Fig. 3D) . Finally, we emphasise that for these particular parameter 
Sensitivity analysis
266
Even if we estimated some parameter values using tumour and macro- For the sensitivity analysis, we vary the initial conditions within the range 274 shown in Table A .4, the model parameters within the range shown in Table   275 A.6, and the ratio k = k 12 /k 21 within the range shown in Table A .3.
276
For each baseline value q of model parameters and initial conditions
277
(that generated the simulations in Figure 3 and which will be referred to 278 13 as the baseline model ), we consider the effect of changing q to q + ∆q, where ∆q is either positive or negative. In particular, if q is a parameter value, 280 then q is changed with 7 incremental steps ∆q = 30%q within the range 281 (−80%q, +190%q) (see Table A .6). If q is an initial condition value, then 282 q is changed with 6 incremental steps within the ranges shown in Table   283 A.4. Finally, if q = k = k 12 /k 21 , then we change k 12 and k 21 simultan-284 eously from 4 × 10 −7 to 4 × 10 −3 in 100 steps creating 10.000 simulations.
285
However, to keep the results tractable, in Table A .3 we present the most 286 informative 7-steps changes in the ratio k, with k 12 ∈ (5 × 10 −5 , 2 × 10 −5 ) 287 and k 21 ∈ (4 × 10 −5 , 1.6 × 10 −5 ).
288
The change from q to q + ∆q leads to a change in the total tumour size (see Figure 3A) , then the change in q leads to a change from X to X + ∆X,
292
where ∆X is the percentage change on day 20. We chose to focus on tumour Moreover, many experimental studies investigate the effect of the ratio
299
M2/M1 on tumour size, to test whether this ratio can be used as a biomarker 300 for tumour development (Herwig et al., 2013) . Therefore, we will use sensit-301 ivity analysis to quantify the relationship between the ratio M2/M1 at day 7
302
(for comparison with the data; see Figure 2 ) and the changes in the tumour 303 population at days 20 and 50, as a result of varying k in the simulations.
304
While a decrease in the tumour might be the most desirable outcome,
305
an increase in the number of days to reach a certain tumour size can extend 306 the life expectancy. Therefore, we introduce a second value, Z, to represent here that we refer to the growth until the tumour reaches half the carrying 312 capacity as early tumour growth.
313
In the following subsections we show the change in the tumour size at days 
Sensitivity to initial conditions
318 Figure 5 shows that changing x T s (0) (within the interval shown in Table   319 A.4) has the greatest effect on the final tumour population (panel A), and on These parameters appear in the steady states for x M 1 and x M 2 , and are in-337 volved in the ratio of M2/M1 macrophages. We will return to these rates in 338 Section 5.3, when we will investigate in more detail the role of k = k 12 /k 21 339 on tumour growth.
Sensitivity to parameters
340
Other parameters that influence tumour dynamics are: k sn , the rate at 341 which the x T s cells become x T n cells; δ mn , the rate at which x T n cells are 
350
In Figure 7B we show the percentage change in tumour size on day 50 versus 351 k. In this case, for k ≥ 1 the tumours stay at their carrying capacity (i.e., no 352 change from the value obtained with the baseline parameters). However, for 353 k < 1, the tumour size on day 50 is reduced between 0-35%, again depending 354 on the specific values of the macrophage re-polarisation rates k 12 and k 21 .
355
We deduce from here that the ratio k = k 12 /k 21 is not a clear indicator of 
387
In Figure 11 we show the ratio M2:M1 at day 7 and 14 (i.e., x M 2 (7)/x M 1 (7) In Figure 12 we show the change in tumour size on day 20 (panel A) and The sensitivity analysis allowed us to identify the parameter values that , when the ratio of M2/M1 macrophages on day 7 is either x M 2 (7)/x M 1 (7) > 1 or x M 2 (7)/x M 1 (7) ≤ 1, as a result of varying k 21 ∈ (1.6 × 10 −5 , 4 × 10 −5 ) and k 12 ∈ (2 × 10 −5 , 5 × 10 −5 ) in 7 steps. (B) Total tumour size on day 50, for x M 2 (7)/x M 1 (7) > 1 and x M 2 (7)/x M 1 (7) ≤ 1, as a result of varying k 21 ∈ (1.6 × 10 −5 , 4 × 10 −5 ) and k 12 ∈ (2 × 10 −5 , 5 × 10 −5 ) in 7 steps.
addition to the expected importance of tumour growth rate r and tumour 427 carrying capacity β T on overall tumour dynamics, two other parameters, Figure 12 we focused on the value of this ratio at 453 day 7). If these results can be confirmed also for human data, then they 
501
Parameter estimation.
502
• To approximate the tumour growth rate r, we fit equation (1a) Fig 2A) .
506
• Most experimental studies euthanise the mice when the tumour reaches there were only 15% M2 macrophages, while on day 14 this percentage 523 increased to 85% M2 macrophages. We use these values to fit k 12 , the 524 rate at which M1 macrophages become M2, and k 21 , the rate at which 525 M2 macrophages become M1 (see Figure 2C) , r mn the proliferation rate For the purpose of this article, we will consider δ mn = δ ms = 2 × 10 −6 , 556 corresponding to an average tumour %Lysis = 65%.
557
Finally, to approximate δ kill for Th1 cells (i.e., δ kill = δ ts ), we note that 
559
The maximum %Lysis was 30%, and was obtained at an effector:target and initial conditions used for the sensitivity analysis in Section 5.
564 Table A .3: Changes in the ratio k = k 12 /k 21 for the sensitivity analysis. k 12 is changed from 5 × 10 −5 to 2 × 10 −5 , and k 21 is changed from 4 × 10 −5 to 1.6 × 10 −5 in 7 steps. To investigate the number of TF1IP states, we substitute x * T h1 given by
566
(2) into the expression for x 
where AppendixC. Jacobian matrix
588
The Jacobian matrix associated with system (1) is given by:
589 T s = 0 is given by the intersection of the surfaces described by the right-hand-sides (RHS) of equations (1a)+(1c) (cyan curves; gray on black/white print) and RHS of equations (1a)+(1d) (black curves). Here, we consider k = k 12 /k 21 = 5 (although different k generate similar curves). Note that there seems to be an infinite number of intersection points between the cyan and black curves. The inset shows the intersection points for x * T n ∈ {1, 2, 3}.
with 590 a 11 = r(1 − x T n + x T s β T ) − r x T n β T − δ mn x M 1 + r mn x M 2 , a 12 = −r x T n β T + k sn , a 13 = −δ mn x T n , a 14 = r mn x T n , a 15 = 0, a 16 = 0, a 21 = −r x T s β T , a 22 = r(1 − x T n + x T s β T ) − r x T s β T − k sn − δ ms x M 1 − δ ts x T h1 , a 23 = −δ ms x ts , a 24 = 0, a 25 = −δ ts x T s , a 26 = 0,
